| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/03/2010 | US20100137595 Vaginal odorants |
| 06/03/2010 | US20100137378 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases |
| 06/03/2010 | US20100137377 Novel compounds |
| 06/03/2010 | US20100137376 Amide compound and method for controlling plant disease using the same |
| 06/03/2010 | US20100137347 5-[3-((1S,2R)-2-{4-[1-(4-Methoxy-benzyloxy)-hexyl]-phenyl}-3-methylene-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester; glaucoma, inflammatory bowel disease, the stimulation of hair growth, and the stimulation of the conversion of vellus hair to terminal hair |
| 06/03/2010 | US20100137336 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 06/03/2010 | US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 06/03/2010 | US20100137323 Benzo-fused compounds for use in treating metabolic disorders |
| 06/03/2010 | US20100137245 Heteerocyclyl-substituted thiazoles as crop protection agents |
| 06/03/2010 | US20100133480 Carbon-nanotube n-doping material and methods of manufacture thereof |
| 06/03/2010 | CA2745004A1 Pyridine-3-carboxyamide derivative |
| 06/02/2010 | EP2192124A1 Transition metal complex and process for producing conjugated aromatic compound with the transition metal complex |
| 06/02/2010 | EP2192115A1 1,3-dimethylbutylcarboxanilides for controlling undesirable micro-organisms |
| 06/02/2010 | EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone |
| 06/02/2010 | EP2191830A1 Solid preparation comprising npyy5 receptor antagonist |
| 06/02/2010 | EP2190834A1 Pyridoneamide derivatives as focal adhesion kinase (fak) inhibitors and their use for the treatment of cancer |
| 06/02/2010 | EP2190811A1 Renin inhibitors |
| 06/02/2010 | EP2190808A1 Leukotriene b4 inhibitors |
| 06/02/2010 | EP2190432A2 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 06/02/2010 | EP2190293A1 Compounds and methods for treating zinc matrix metalloprotease dependent diseases |
| 06/02/2010 | EP1828142B1 Method for producing onium alkyl sulfates with a low halogenide content |
| 06/02/2010 | EP1658263B1 Novel aminobenzophenone compounds |
| 06/02/2010 | EP1417200B1 Substituted 1h-dihydropyrazoles, their preparation and use |
| 06/02/2010 | EP1416797B1 Arthropodicidal anthranilamides |
| 06/02/2010 | EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 06/02/2010 | CN101717422A Method for producing dehydroepiandros-sterone |
| 06/02/2010 | CN101717393A Derivate of cyclohexyl 2, 5-2 substituted phenyl ether and application thereof |
| 06/02/2010 | CN101717369A Method for preparing arylamine by catalysis in aqueous phase |
| 06/02/2010 | CN101717365A Method for purification of torasemide and preparation of big crystal form |
| 06/02/2010 | CN101717364A Paradoximes as HIV reverse transcriptase inhibitor as well as preparation method and purpose thereof |
| 06/02/2010 | CN101035761B 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt |
| 06/01/2010 | US7728137 with Tris(2-bromo-6-pyridyl)phosphine oxide ligands; organic light-emitting diodes, integrated circuits, organic field-effect transistors, thin-film transistors, organic solar cells, and/or laser diodes |
| 06/01/2010 | US7728019 Biphenylcarboxamides |
| 06/01/2010 | US7728014 Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity |
| 06/01/2010 | US7728013 derivatives of pirfenidone which can modulate a stress activated protein kinase (SAPK) system; treatment of various inflammatory conditions and/or fibrotic conditions such as inflammatory pulmonary fibrosis and/or idiopathic pulmonary fibrosis |
| 06/01/2010 | US7728011 Dermally applicable liquid formulations for controlling parasitic insects on animals |
| 06/01/2010 | US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity |
| 06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 06/01/2010 | US7727982 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
| 06/01/2010 | US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders |
| 06/01/2010 | CA2457965C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 06/01/2010 | CA2415169C Novel c-4 substituted retinoids |
| 05/27/2010 | WO2010059838A2 Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects |
| 05/27/2010 | WO2010059611A2 Inhibitors of diacylglycerol acyltransferase |
| 05/27/2010 | WO2010059503A2 PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO[2,3-d]PYRIMIDINE-4,7(3H,8H)-DIONE AND INTERMEDIATES THEREOF |
| 05/27/2010 | WO2010059372A2 Tryptase enzyme inhibiting aminopyridines |
| 05/27/2010 | WO2010058995A1 Electroluminescent device using the electroluminescent compounds |
| 05/27/2010 | WO2010058846A1 4,6-diaminonicotinamide compound |
| 05/27/2010 | WO2010057922A1 Curable composition comprising a thermolatent base |
| 05/27/2010 | WO2010057865A1 N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators |
| 05/27/2010 | WO2010057833A1 Compounds for treatment of duchenne muscular dystrophy |
| 05/27/2010 | WO2009156462A3 Organic compounds |
| 05/27/2010 | WO2009018367A3 Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-methoxypyridin)yl]-4-penten-2-amine |
| 05/27/2010 | US20100130737 Regulating Agent of GPR34 Receptor Function |
| 05/27/2010 | US20100130555 Compositions and methods for treating or preventing hypoxic or ischemic injury |
| 05/27/2010 | US20100130545 Bridged six-membered ring compounds |
| 05/27/2010 | US20100130522 Compounds for inflammation and immune-related uses |
| 05/27/2010 | US20100130497 Therapeutic Compounds |
| 05/27/2010 | US20100129471 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization |
| 05/27/2010 | US20100129321 Diaryl urea for treating virus infections |
| 05/27/2010 | US20100127213 Liquid crystalline medium and liquid crystal display |
| 05/27/2010 | US20100127212 Pyridine compounds for liquid-crystalline mixtures |
| 05/27/2010 | CA2743497A1 Inhibitors of diacylglycerol acyltransferase |
| 05/27/2010 | CA2742785A1 Process for making (r) -3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione and intermediates thereof |
| 05/26/2010 | EP2189443A1 Tricyclic amide compound |
| 05/26/2010 | EP2189439A2 CaSR antagonist |
| 05/26/2010 | EP2188258A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products |
| 05/26/2010 | EP2188257A2 Sulfoximine derivatives as factor xa inhibitors |
| 05/26/2010 | EP2188256A1 Renin inhibitors |
| 05/26/2010 | EP2188255A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 05/26/2010 | EP2188254A1 Novel bradykinin b1-antagonists |
| 05/26/2010 | EP1730103B1 Formamide derivatives useful as adrenoceptor |
| 05/26/2010 | EP1572656B1 Compounds useful as pesticides |
| 05/26/2010 | CN1966494B 2-chloro-5-chloromethyl pyridine refining method |
| 05/26/2010 | CN1910153B Derivatives of pyridine and quinoline |
| 05/26/2010 | CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 05/26/2010 | CN1631144B Biocidal composition and its use |
| 05/26/2010 | CN1520702B Electroluminescent irisium compounds with fluorinated phenylpyridines, phenylpyridines and phenylquinolines and device made with such compounds |
| 05/26/2010 | CN1391469B Npyy5拮抗剂 Npyy5 antagonist |
| 05/26/2010 | CN1359390B Factor VII a inhibitors |
| 05/26/2010 | CN101712867A Organic electronic transmission and/or hole barrier materials, synthetic method and applications thereof |
| 05/26/2010 | CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 05/26/2010 | CN101712657A heteroarylcarbamoylbenzene derivative |
| 05/26/2010 | CN101712653A Pyridazine derivatives and their use as therapeutic agents |
| 05/26/2010 | CN101712647A Metal complex for optical recording material and preparation method as well as prepared optical recording dye thereof |
| 05/26/2010 | CN101712632A Substituted tetracycline compounds |
| 05/26/2010 | CN101074211B Process for treating high-purity pyridine solution |
| 05/26/2010 | CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 05/25/2010 | US7723536 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 05/25/2010 | US7723522 Pyridine derivative production method |
| 05/25/2010 | US7723494 Yellow anionic disazo dyes |
| 05/25/2010 | US7723364 N-[2-(2-pyridinyl) ethyl]benzamide compounds and their use as fungicides |
| 05/25/2010 | US7723358 such as hypertriglyceridaemia, hypercholesterolemia, dyslipidaemia, or obesity; 6-methyl-N-[3-[[1-(methylsulfonyl)-4-piperidinyl]oxy]phenyl]-4'-(trifluoro-methoxy) [1,1'-biphenyl]-2-carboxamide |
| 05/25/2010 | US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus |
| 05/25/2010 | CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials |
| 05/20/2010 | WO2010057101A2 Compounds useful as hiv blockers |
| 05/20/2010 | WO2010056726A1 Compositions and methods for treating diabetes |
| 05/20/2010 | WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 05/20/2010 | WO2010056527A2 Fused heterocyclic compounds as ion channel modulators |
| 05/20/2010 | WO2010055887A1 Novel sulfonium salt, method for producing same and use of same |